
Tasisulam
CAS No. 519055-62-0
Tasisulam ( LY 573636 )
产品货号. M14817 CAS No. 519055-62-0
Tasisulam (LY 573636) 是一种小分子抗肿瘤剂,可通过内在途径诱导细胞凋亡,导致细胞色素 c 释放和 caspase 依赖性细胞死亡。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥284 | 有现货 |
![]() ![]() |
10MG | ¥454 | 有现货 |
![]() ![]() |
25MG | ¥1021 | 有现货 |
![]() ![]() |
50MG | ¥1742 | 有现货 |
![]() ![]() |
100MG | ¥2608 | 有现货 |
![]() ![]() |
200MG | ¥3912 | 有现货 |
![]() ![]() |
500MG | ¥6391 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Tasisulam
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Tasisulam (LY 573636) 是一种小分子抗肿瘤剂,可通过内在途径诱导细胞凋亡,导致细胞色素 c 释放和 caspase 依赖性细胞死亡。
-
产品描述Tasisulam (LY 573636) is a small molecule antitumor agent that induces apoptosis via the intrinsic pathway, resulting in cytochrome c release and caspase-dependent cell death; shows antiproliferative effect against a variety of human hematopoietic malignancies, including AML, B-ALL, large B-cell and mantle cell lymphoma cell lines; promotes the recruitment of RBM39 to the CUL4-DCAF15 E3 ubiquitin ligase, leading to RBM39 polyubiquitination and proteasomal degradation; causes aberrant pre-mRNA splicing.Blood Cancer Phase 1 Discontinued(In Vitro):Tasisulam (200 nM-200 μM; 48 hours) induces an antiproliferative response across a wide range of tumor histologies with EC50s of 10 μM and 25 μM for Calu-6 and A-375 cell lines, respectively.Tasisulam (25, 50 μM; 72 hours) induces a concentration-dependent increase in 4N DNA and G2-M accumulation.Tasisulam (200 nM-200 μM; 48 hours) induces apoptosis in a broad range of in vitro cancer cell models.Tasisulam also blocks VEGF, epidermal growth factor, and fibroblast growth factor-induced endothelial cell cord formation.
-
体外实验Tasisulam (200 nM-200 μM; 48 hours) induces an antiproliferative response across a wide range of tumor histologies with EC50s of 10 μM and 25 μM for Calu-6 and A-375 cell lines, respectively. Tasisulam (25, 50 μM; 72 hours) induces a concentration-dependent increase in 4N DNA and G2-M accumulation. Tasisulam (200 nM-200 μM; 48 hours) induces apoptosis in a broad range of in vitro cancer cell models. Tasisulam also blocks VEGF, epidermal growth factor, and fibroblast growth factor-induced endothelial cell cord formation. Cell Proliferation Assay Cell Line:Calu-6 non-small cell lung carcinoma and A-375 melanoma models.Concentration:200 nM-200 μM Incubation Time:48 hours Result:Induced an antiproliferative response across a wide range of tumor histologies with EC50s are 10 μM and 25 μM, respectively.Cell Cycle Analysis Cell Line:Calu-6 and A-375 cell lines Concentration:25, 50 μM Incubation Time:72 hours Result:Induced a concentration-dependent increase in 4N DNA and G2-M accumulation.Apoptosis Analysis Cell Line:Calu-6 non-small cell lung carcinoma and A-375 melanoma models Concentration:200 nM-200 μM Incubation Time:48 hours Result:Induced apoptosis in a broad range of in vitro cancer cell models.
-
体内实验——
-
同义词LY 573636
-
通路Proteasome/Ubiquitin
-
靶点E3 Ubiquitin Ligase
-
受体Caspase
-
研究领域Cancer
-
适应症Blood cancer
化学信息
-
CAS Number519055-62-0
-
分子量415.1
-
分子式C11H6BrCl2NO3S2
-
纯度>98% (HPLC)
-
溶解度DMSO: 77 mg/mL (185.5 mM); Ethanol: 77 mg/mL (185.5 mM); Water: <1 mg/mL ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=S(C1=CC=C(Br)S1)(NC(C2=CC=C(Cl)C=C2Cl)=O)=O
-
化学全称N-[(5-bromo-2-thienyl)sulfonyl]-2,4-dichloro-benzamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Meier T, et al. Mol Cancer Ther. 2011 Nov;10(11):2168-78.
2. Haritunians T, et al. Oncol Rep. 2008 Nov;20(5):1237-42.
3. Han T, et al. Science. 2017 Apr 28;356(6336). pii: eaal3755.
产品手册




关联产品
-
Tasisulam
Tasisulam (LY 573636) 是一种小分子抗肿瘤剂,可通过内在途径诱导细胞凋亡,导致细胞色素 c 释放和 caspase 依赖性细胞死亡。
-
cIAP1 E3 ligase inhi...
cIAP1 E3 连接酶抑制剂 D19 (cIAP1抑制剂D19)是cIAP1 E3连接酶活性的小分子抑制剂,抑制cIAP1自动泛素化,IC50为14.1 uM。
-
Suramin sodium salt
苏拉明钠盐 (BAY-205, NF-060) 是一种抗锥虫化合物,还具有抗肿瘤活性;通过破坏其募集 Cdc34 的能力来抑制 CRL(Cullin-RING E3 泛素连接酶)活性。